non-small cell lung cancer Clinical Research Trials

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (54)

Phase 0 (1)
Phase 1 (10)
Phase 1/2 (7)
Phase 2 (17)
Phase 3 (9)
Unknown (10)

Interventional (47)
Observational (6)

Hoffmann-La Roche (3)
BeiGene (2)
National Cancer Institute (NCI) (2)
Sanofi (2)
Second Affiliated Hospital, School of Medicine, Zhejiang University (2)
Sun Yat-sen University (2)
AIO-Studien-gGmbH (1)
AbbVie (1)
Adcentrx Therapeutics (1)
Ascentage Pharma Group Inc. (1)
Atreca, Inc. (1)
Beijing Pearl Biotechnology Limited Liability Company (1)
Blueprint Medicines Corporation (1)
Calithera Biosciences, Inc (1)
City of Hope Medical Center (1)
European Lung Cancer Working Party (1)
Fudan University (1)
Fundación GECP (1)
Genentech, Inc. (1)
Guangdong Association of Clinical Trials (1)
Guangzhou Institute of Respiratory Disease (1)
Gustave Roussy, Cancer Campus, Grand Paris (1)
Hospital Israelita Albert Einstein (1)
Icahn School of Medicine at Mount Sinai (1)
Istituto Clinico Humanitas (1)
JS InnoPharm, LLC (1)
Karyopharm Therapeutics Inc (1)
Merck Sharp & Dohme Corp. (1)
Mersana Therapeutics (1)
National Hospital Organization Nagoya Medical Center (1)
Oslo University Hospital (1)
Persephone Biosciences (1)
Scott R. Plotkin, MD, PhD (1)
Seattle Genetics, Inc. (1)
ShangHai HaiHe Pharmaceutical (1)
Shanghai JMT-Bio Inc. (1)
Shanghai Pulmonary Hospital, Shanghai, China (1)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)
Spectrum Pharmaceuticals, Inc (1)
Swiss Group for Clinical Cancer Research (1)
The Netherlands Cancer Institute (1)
The University of Hong Kong (1)
Universitaire Ziekenhuizen Leuven (1)
Wake Forest University Health Sciences (1)
Xuanwu Hospital, Beijing (1)
Yuhan Corporation (1)

No (54)

No (54)

Adult (18+) (54)
Pediatric (Under 18) (3)

I am/have/had

I am/have/hadnon-small cell lung cancer

I am/have/hadlung cancer

I am/have/hadsmall cell lung cancer

I am/have/hadmeasurable disease

I am/have/hadcancer

I am/have/hadstage iv non-small cell lung cancer

I am/have/hadmetastasis

I am/have/hadalopecia

I am/have/hadsolid tumour

I am/have/hadgilbert's syndrome

I am/have/hadbrain metastases

I am/have/hadneutrophil count

I am/have/hadbrain metastasis

I am/have/hadcancer chemotherapy

I am/have/hadchemoradiotherapy

I am/have/hadsquamous non-small cell lung cancer

I am/have/hadhair thinning

I am/have/hadplatelet count

I am/have/hadstereotactic body radiation therapy

I am/have/hadBRAF

added new label for I am/have/had

I am looking for

I am looking forpemetrexed

I am looking forcarboplatin

I am looking forgefitinib

I am looking forcisplatin

I am looking forepidermal growth factor

I am looking forpaclitaxel

I am looking fordocetaxel

I am looking fortyrosine

I am looking forgrowth factor

I am looking forpembrolizumab

I am looking forgemcitabine

I am looking forplatinum doublet

I am looking foradjuvant

I am looking forplatinum-based chemotherapy

I am looking forosimertinib

I am looking formelanoma

I am looking forkras

I am looking fornivolumab

I am looking formonoclonal antibodies

I am looking foratezolizumab

added new label for I am looking for

Advanced Filters

Found 1739 clinical trials

None

None views

Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Family Medicine
Recruiting

Multimodality Treatment in Stage III Non-small Cell Lung Cancer (NSCLC)

Resectable, locally advanced NSCLC with involvement of mediastinal lymph nodes (N2) is associated with a high risk of (systemic) recurrence despite neo-adjuvant chemotherapy.

durvalumab

measurable disease

combined modality therapy

stage iii non-small cell lung cancer

small cell lung cancer

0 views
19 Feb, 2024
13 locations

Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Thoracic Re-irradiation For Locoregionally Recurrent Non-small Cell Lung Cancer

This prospective phase II study is to assess the efficacy and safety of thoracic re-irradiation for locoregionally recurrent non-small cell lung cancer using hypofractionated technique.

0 views
19 Feb, 2024
1 location

For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Recruiting

Prediction of Immunotherapeutic Effect of Advanced Non-small Cell Lung Cancer

To detect the difference of PD-L1 and miRNA expression profiles of exosomes in NSCLC patients before and after immunotherapy, and to explore the potential of plasma exosomes PD-L1 and miRNAs as biomarkers to predict the therapeutic effect of NSCLC on anti-PD-1 / PD-L1.

0 views
19 Feb, 2024
1 location